To assess the effect of loss of AHNAK2 upon cancer cell motility, we used a hanging drop spheroid invasion assay developed in our laboratory, allowing assessment of 3D physiomimetic invasion38 (Fig. 6A). This evidence concerns the gene AHNAK2 and cancer.